Asklepios BioPharma

posted on September 1, 2008 - 10:07am
Real progress is being made in supplying functional dystrophin genes to treat Duchenne muscular dystrophy (DMD), a disease in which mutated dystrophin genes keep this critical protein from being produced in muscle fibers.
posted on March 29, 2006 - 10:51am
The first U.S. human gene therapy trial directed at Duchenne muscular dystrophy (DMD) was launched yesterday at Columbus (Ohio) Children's Hospital, the Muscular Dystrophy Association (MDA), Children’s Hospital, and Asklepios Biopharmaceutical Inc. (AskBio) announced today.  Neurologist Jerry Mendell administered an injection of AskBio’s Biostrophin, which contains a functional gene for the...